{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Sivifene",
  "nciThesaurus": {
    "casRegistry": "2675-35-6",
    "chebiId": "",
    "chemicalFormula": "C19H14N4O6",
    "definition": "The phenylhydrazone 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone formulated as a topical agent with immunomodulating and potential antineoplastic activities. Applied topically as a gel, sivifene may stimulate a local immune response against human papillomavirus (HPV)-induced cervical intraepithelial neoplasia (CIN).",
    "fdaUniiCode": "XAV05295I5",
    "identifier": "C61305",
    "preferredName": "Sivifene",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C2139"
    ],
    "synonyms": [
      "4,4'-Dihydroxybenzophenone 2,4-dinitrophenylhydrazone",
      "A-007",
      "Aryl Hydrazone A-007 Gel",
      "SIVIFENE",
      "Sivifene"
    ]
  }
}